secwatch.observer — SEC 8-K summary
======================================

Issuer:     Unicycive Therapeutics, Inc. (UNCY)
CIK:        0001766140
Form:       8-K
Filed at:   2025-01-07T23:59:59+00:00
Accession:  0001213900-25-001640
Event type: regulatory
Sentiment:  neutral
Materiality: 0.55
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Unicycive gets Nasdaq extension to July 7, 2025 to meet $1 bid price
--------------------------------------------------------------------

- Initial non-compliance notice received July 9, 2024; 180-day cure period ended Jan 6 without compliance.
- Nasdaq granted an additional 180 calendar days, until July 7, 2025, to regain $1.00 minimum bid.
- Company will monitor bid price and may consider options such as a reverse stock split if needed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1766140/000121390025001640/0001213900-25-001640-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1766140/000121390025001640/ea0227071-8k_unicycive.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-001640

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer